Working Toward a Cure: New Psoriasis Bill Introduced in Congress

Patient Expert
iStock

The Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011 (PPARCCA), spearheaded by the National Psoriasis Foundation and its advocates, was introduced in Congress by Sen. Robert Menendez (D-NJ) and Rep. Jim Gerlach (R-Pa.-6th) in the House of Representatives with the support of Rep. Charles Gonzalez (D-Texas-20th).

Why is this bill so significant? It shed light on the seriousness of psoriasis and psoriatic arthritis and advances the nation's efforts to find cures for these diseases.

If passed, the Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011 would:

  • Secure $1.5 million a year (2012-2017) to continue the psoriasis data collection project.

PPARCCA calls for a six-year investment toward understanding the public health impacts of psoriatic disease. The project began with $1.5 million allocated to the Centers for Disease Control and Prevention (CDC)  by Congress in 2009. CDC researchers have completed the first phase of the project. Without continued funding, this initial investment will be lost.

  • NPF and others are bringing scientists from different disciplines together to study the connections between psoriatic disease and other serious health conditions.

PPARCCA calls on the National Institutes of Health (NIH) to join these efforts-forming a strong public-private partnership to find a cure.